Suzanne Louise Bruhn
CIK 1517790 · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.70M
Companies
10
Total Filings
59
Lifetime Open-Market Net
-$904.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Director | 32,750 | $52.04 | $1.70M | $0 | 6 | 2026-05-21 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | Director | 0 | $8.05 | $0 | $0 | 9 | 2025-08-05 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Director | 19,623 | $15.00 | $294.3K | $0 | 4 | 2025-06-16 |
| PLRX | Director | — | $1.13 | — | $0 | 5 | 2025-06-09 |
| AVTX | Director | — | $14.76 | — | $0 | 1 | 2021-10-04 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | — | $2.93 | — | $0 | 8 | 2021-07-02 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 4 | 2020-06-10 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 5,250 | — | — | $0 | 1 | 2020-04-09 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | Director | — | — | — | $0 | 2 | 2018-08-13 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 8,330 | — | — | -$904.6K | 19 | 2016-10-26 |
Recent Filings · Page 3 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-21 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2022-05-12 | TVTX | Grant (A) | +3,000 | $0 | EDGAR |
| 2021-10-04 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-18 | TVTX | Grant (A) | +3,000 | $0 | EDGAR |
| 2021-04-02 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.